© Nils Huenerfuerst
On 25 September 2025, Heads of State and Government will gather in New York during the UN General Assembly (UNGA) for the fourth UN High-level Meeting (HLM) on the prevention and control of noncommunicable diseases (NCDs) and the promotion of mental health and wellbeing.
This will be the first HLM on NCDs since 2018, and it comes at a decisive moment—just five years before the 2030 deadline for the Sustainable Development Goals (SDGs). The meeting takes place against a backdrop of increasing financial pressures, shrinking external development assistance, and a continually rising burden of NCDs worldwide.
Access Accelerated will contribute to these discussions by convening and joining events and bringing country insights.
Where do we go from here? Rethinking financing for NCDs and mental health
Monday, 22 September
By registration
Hosted by Devex | Supported by Access Accelerated, AstraZeneca, and Boehringer Ingelheim.
A high-level gathering featuring panels and interactive roundtables. The session will explore how global commitments from HLM4 can be translated into locally-led, sustainable health financing solutions for NCDs and mental health.
Japan’s Innovation and Multi-Stakeholder Partnerships for Tackling NCDs: Advancing the Pathway to UHC
Wednesday, 24 September
By invitation only
Hosted by
Japan Pharmaceutical Manufacturers Association (JPMA) and the Permanent Mission of Japan to the United Nations (JPN Mission) | Supported by IFPMA
Highlighting Japanese innovations and case studies that catalyze international dialogue and cooperation for NCD prevention, control, and progress toward Universal Health Coverage (UHC).
Panel moderation by Herb Riband, Access Accelerated
Advancing Access and Financing for NCD Medicines and Products
Wednesday, 24 September
By invitation only
Hosted by the Consulate General of Denmark in New York, Ministry of Health of Brazil (Ministério da Saúde), PATH, Coalition for Access to NCD Medicines & Products, Novo Nordisk, IGBA, and Access Accelerated
A session spotlighting country leadership, financing mechanisms, and access solutions that can accelerate progress in NCD prevention and care.